학술논문

Daratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN
Document Type
Article
Source
In Blood Advances 23 February 2021 5(4):1092-1096
Subject
Language
ISSN
2473-9529